A Study of the Effects of Erythromycin on the Pharmacokinetics of Relugolix, Estradiol, and Norethindrone in Healthy Postmenopausal Women and on the Pharmacokinetics of Relugolix in Healthy Adult Men
Clinical trial NCT04714554 · COMPLETED
Trial details
- NCT number
- NCT04714554
- Sponsor
- Myovant Sciences GmbH
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-06
- Primary completion
- 2021-03-29
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.